Hypertriglyceridaemia [fndg]
secondary [neop]
Obesity [dsyn]
Diabetes [dsyn]
Hypertriglyceridaemia [fndg]
Lipid [lipd]
Abnormality [fndg]
Persons [popg]
Obesity, Visceral [sosy]
Metabolic syndrome [dsyn]
Type 2 Diabetes [dsyn]
Hypertriglyceridaemia [fndg]
low hdl [fndg]
Levels [qlco]
Atherogenesis [patf]
Small [qnco]
Dense [qlco]
LDL particle [celc]
Increased [qnco]
CARDIOVASCULAR [bdsy]
Insulin Resistance [patf]
Often [tmco]
Increased [qnco]
free fatty acid [lipd]
Delivery [topp]
Increased Lipolysis [moft]
Peripheral [spco]
Increased VLDL [fndg]
Hepatic [blor]
production [ocac]
Increased [qnco]
Substrate [mnob]
Availability [ftcn]
ffas [lipd]
Decreased [qnco]
Apolipoprotein B100 [aapp, bacs]
degradation [ftcn]
Increased Lipogenesis [moft]
Postprandial [tmco]
Hypertriglyceridaemia [fndg]
Insulin Resistance [patf]
Small [qnco]
Dense [qlco]
Decreased HDL [fndg]
particles [chvs]
Highly [qlco]
Pro [aapp, bacs]
Atherogenesis [patf]
Enhanced [acty]
Endothelial [tisu]
Permeability [npop]
proteoglycan binding [moft]
Abilities [orga]
Susceptibility [clna]
Oxidation [moft]
Hypertriglyceridaemia [fndg]
Type 1 diabetes [dsyn]
GLUCOSE CONTROL [irda]
Normalize [resa]
Lipid [lipd]
Abnormalities [cgab]
Obesity, Visceral [sosy]
Patients [podg]
Metabolic Profile [npop]
Patients [podg]
Insulin Resistance [patf]
Hypertriglyceridaemia [fndg]
CARDIOVASCULAR [bdsy]
Marked [qlco]
Hypertriglyceridaemia [fndg]
considered [idcn]
Pancreatitis [dsyn]
Life Style [socb]
Modification [ftcn]
Therapeutic [topp]
strategy [menp]
Drug Therapy [topp]
Focused [spco]
lowering [spco]
Statins [orch, phsu]
Effort [orgf]
Triglyceride [bacs, lipd]
lowering [spco]
hdl raising [fndg]
Fibrates [orch, phsu]
Niacin [orch, phsu, vita]
Improving [qlco]
CARDIOVASCULAR [bdsy]
Fibrates [orch, phsu]
Line [spco]
Agent [chvf]
Marked [qlco]
Hypertriglyceridaemia [fndg]
Present [qnco]
Article [inpr]
Part [spco]
Special [qlco]
Issue [fndg]
Triglyceride Metabolism [moft]
Reserve [acty]
